BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19834617)

  • 1. Genetic regulation of alpha-synuclein mRNA expression in various human brain tissues.
    Linnertz C; Saucier L; Ge D; Cronin KD; Burke JR; Browndyke JN; Hulette CM; Welsh-Bohmer KA; Chiba-Falek O
    PLoS One; 2009 Oct; 4(10):e7480. PubMed ID: 19834617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of SNCA 3' region on the levels of SNCA-112 splicing variant.
    McCarthy JJ; Linnertz C; Saucier L; Burke JR; Hulette CM; Welsh-Bohmer KA; Chiba-Falek O
    Neurogenetics; 2011 Feb; 12(1):59-64. PubMed ID: 21046180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients.
    Chiba-Falek O; Lopez GJ; Nussbaum RL
    Mov Disord; 2006 Oct; 21(10):1703-8. PubMed ID: 16795004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human alpha-synuclein in transgenic mouse brain.
    Cronin KD; Ge D; Manninger P; Linnertz C; Rossoshek A; Orrison BM; Bernard DJ; El-Agnaf OM; Schlossmacher MG; Nussbaum RL; Chiba-Falek O
    Hum Mol Genet; 2009 Sep; 18(17):3274-85. PubMed ID: 19498036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain.
    Fuchs J; Tichopad A; Golub Y; Munz M; Schweitzer KJ; Wolf B; Berg D; Mueller JC; Gasser T
    FASEB J; 2008 May; 22(5):1327-34. PubMed ID: 18162487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypomethylation of SNCA in blood of patients with sporadic Parkinson's disease.
    Ai SX; Xu Q; Hu YC; Song CY; Guo JF; Shen L; Wang CR; Yu RL; Yan XX; Tang BS
    J Neurol Sci; 2014 Feb; 337(1-2):123-8. PubMed ID: 24326201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene.
    Chiba-Falek O; Kowalak JA; Smulson ME; Nussbaum RL
    Am J Hum Genet; 2005 Mar; 76(3):478-92. PubMed ID: 15672325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-synuclein transcript isoforms in three different brain regions from Parkinson's disease and healthy subjects in relation to the SNCA rs356165/rs11931074 polymorphisms.
    Cardo LF; Coto E; de Mena L; Ribacoba R; Mata IF; Menéndez M; Moris G; Alvarez V
    Neurosci Lett; 2014 Mar; 562():45-9. PubMed ID: 24418406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcript expression levels of full-length alpha-synuclein and its three alternatively spliced variants in Parkinson's disease brain regions and in a transgenic mouse model of alpha-synuclein overexpression.
    McLean JR; Hallett PJ; Cooper O; Stanley M; Isacson O
    Mol Cell Neurosci; 2012 Feb; 49(2):230-9. PubMed ID: 22155155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
    Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variant in the 3' region of SNCA associated with Parkinson's disease and serum α-synuclein levels.
    Hu Y; Tang B; Guo J; Wu X; Sun Q; Shi C; Hu L; Wang C; Wang L; Tan L; Shen L; Yan X; Zhang H
    J Neurol; 2012 Mar; 259(3):497-504. PubMed ID: 21853288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered machinery of protein synthesis is region- and stage-dependent and is associated with α-synuclein oligomers in Parkinson's disease.
    Garcia-Esparcia P; Hernández-Ortega K; Koneti A; Gil L; Delgado-Morales R; Castaño E; Carmona M; Ferrer I
    Acta Neuropathol Commun; 2015 Dec; 3():76. PubMed ID: 26621506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [SNCA rs356219 AND rs356165 VARIANTS ARE ASSOCIATED WITH PARKINSON'S DISEASE AND INCREASED ALPHA-SYNUCLEIN GENE EXPRESSION IN THE CD45(+)-BLOOD CELLS].
    Emelyanov AK; Andoskin PA; Miliukhina IV; Timofeeva AA; Yakimovskii AF; Senkevich KA; Nikolaev MA; Pchelina SN
    Tsitologiia; 2016; 58(2):99-104. PubMed ID: 27228655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system.
    Chiba-Falek O; Nussbaum RL
    Hum Mol Genet; 2001 Dec; 10(26):3101-9. PubMed ID: 11751692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Variants of SNCA Are Associated with Susceptibility to Parkinson's Disease but Not Amyotrophic Lateral Sclerosis or Multiple System Atrophy in a Chinese Population.
    Chen Y; Wei QQ; Ou R; Cao B; Chen X; Zhao B; Guo X; Yang Y; Chen K; Wu Y; Song W; Shang HF
    PLoS One; 2015; 10(7):e0133776. PubMed ID: 26208350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-synuclein and familial Parkinson's disease.
    Pankratz N; Nichols WC; Elsaesser VE; Pauciulo MW; Marek DK; Halter CA; Wojcieszek J; Rudolph A; Pfeiffer RF; Foroud T;
    Mov Disord; 2009 Jun; 24(8):1125-31. PubMed ID: 19412953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic copy number gains of α-synuclein (SNCA) in Parkinson's disease and multiple system atrophy brains.
    Mokretar K; Pease D; Taanman JW; Soenmez A; Ejaz A; Lashley T; Ling H; Gentleman S; Houlden H; Holton JL; Schapira AHV; Nacheva E; Proukakis C
    Brain; 2018 Aug; 141(8):2419-2431. PubMed ID: 29917054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Lewy body protein septin 4 in postmortem brain of Parkinson's disease and control subjects.
    Shehadeh L; Mitsi G; Adi N; Bishopric N; Papapetropoulos S
    Mov Disord; 2009 Jan; 24(2):204-10. PubMed ID: 18951507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
    Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
    Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level.
    Mata IF; Shi M; Agarwal P; Chung KA; Edwards KL; Factor SA; Galasko DR; Ginghina C; Griffith A; Higgins DS; Kay DM; Kim H; Leverenz JB; Quinn JF; Roberts JW; Samii A; Snapinn KW; Tsuang DW; Yearout D; Zhang J; Payami H; Zabetian CP
    Arch Neurol; 2010 Nov; 67(11):1350-6. PubMed ID: 21060011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.